These genes are normally expressing at very low levels in the hepatocytes, but CD36 expression increases in NASH patients and VLDLR increases in some pathological conditions, such as obesity, diabetes, and NAFLD [52]. The gene discussed is CD36; the disease is metabolic dysfunction-associated steatotic liver disease.